Baird Financial Group, Inc. - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baird Financial Group, Inc. ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$706,391
-54.0%
61,586
+1.5%
0.00%
-50.0%
Q2 2023$1,534,950
-22.6%
60,646
-1.5%
0.00%
-20.0%
Q1 2023$1,983,267
+180197.0%
61,573
+3.4%
0.01%
+66.7%
Q4 2022$1,100
-99.9%
59,560
+0.9%
0.00%
-40.0%
Q3 2022$1,594,000
+17.9%
59,044
+21.7%
0.01%
+66.7%
Q3 2021$1,352,000
+16.9%
48,515
+24.3%
0.00%0.0%
Q2 2021$1,157,000
+51.8%
39,027
+43.1%
0.00%
+50.0%
Q1 2021$762,000
+57.4%
27,267
+41.7%
0.00%0.0%
Q3 2020$484,000
+26.0%
19,244
+22.3%
0.00%
+100.0%
Q2 2020$384,000
-70.1%
15,741
-83.3%
0.00%
-91.7%
Q2 2016$1,283,000
-30.8%
94,308
-11.3%
0.01%
-33.3%
Q1 2016$1,855,000
-34.3%
106,265
+28.6%
0.02%
-35.7%
Q4 2015$2,822,000
+36.5%
82,610
+18.9%
0.03%
+27.3%
Q3 2015$2,068,000
+89.2%
69,496
+103.3%
0.02%
+100.0%
Q2 2015$1,093,00034,1810.01%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$94,714,00024.58%
Palo Alto Investors LP 2,673,313$75,762,0003.97%
Evolutionary Tree Capital Management, LLC 89,348$2,532,0001.93%
RICE HALL JAMES & ASSOCIATES, LLC 1,121,152$31,773,0001.12%
ArrowMark Colorado Holdings LLC 2,964,135$84,004,0000.65%
Rhenman & Partners Asset Management AB 220,000$6,235,0000.51%
Fosun International Ltd 233,841$6,627,0000.43%
OSTERWEIS CAPITAL MANAGEMENT INC 174,970$4,959,0000.30%
ESSEX INVESTMENT MANAGEMENT CO LLC 76,671$2,173,0000.27%
Tekla Capital Management LLC 213,808$6,059,0000.21%
View complete list of REVANCE THERAPEUTICS INC shareholders